NCT00004065View on ClinicalTrials.gov

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1999

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Bladder CancerBreast CancerColorectal CancerGastric CancerHead and Neck CancerKidney CancerLeukemiaLung CancerMelanoma (Skin)Ovarian CancerProstate CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

tanespimycin

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

90095

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00004065 - Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | Biotech Hunter | Biotech Hunter